Panacea Index Logo

Command Palette

Search for a command to run...

Testing the efficacy of yoga as a complementary therapy for smoking cessation: design and methods of the BreathEasy trial.

Contemporary clinical trials
July 1, 2014
Beth C Bock et al. (11 authors)
Journal ArticleRandomized Controlled TrialHuman StudyClinical
Study Details

Study Goal

The researchers aimed to determine whether Iyengar yoga, as a complementary therapy to cognitive-behavioral therapy, improves smoking cessation outcomes by enhancing mindfulness and cognitive deliberation.

Results Summary

The study design suggests rigorous testing of yoga's efficacy compared to a control condition, with planned assessments of prolonged abstinence and mechanisms of action, but final results are not yet reported in the abstract.

Population

Smokers attempting to quit.

Effective Dosage

Twice-weekly yoga sessions.

Duration

8-week program with follow-ups at 3, 6, and 12 months.

Interactions

None mentioned

Extracted Claims (7)
InterventionDirectionEndpointPopulationDosageImpactClaim #
yoga
decrease
stress
non-smoking populations
-
reduces
#1
yoga
decrease
negative mood
non-smoking populations
-
reduces
#2
yoga
increase
weight control
non-smoking populations
-
improves
#3
yoga
increase
smokers' ability to cope with the negative symptoms associated with quitting
smokers
-
may also improve
#4
yoga
increase
cognitive deliberation
-
-
may also improve
#5
Iyengar yoga
neutral
smoking cessation
participants
-
examining the efficacy of
#6
yoga
increase
intervention efficacy
-
-
may be more effective than
#7
Abstract

INTRODUCTION: Smokers trying to quit encounter many challenges including nicotine withdrawal symptoms, cigarette craving, increased stress and negative mood and concern regarding weight gain. These phenomena make it difficult to successfully quit smoking. Studies in non-smoking populations show that yoga reduces stress and negative mood and improves weight control. By increasing mindfulness we anticipate that yoga may also improve smokers' ability to cope with the negative symptoms associated with quitting. Yoga may also improve cognitive deliberation which is needed to make effective choices and avoid smoking in tempting situations. METHODS/DESIGN: The BreathEasy study is a rigorous, randomized controlled clinical trial examining the efficacy of Iyengar yoga as a complementary therapy to cognitive-behavioral therapy for smoking cessation. All participants are given an 8-week program of smoking cessation classes, and are randomized to either twice weekly yoga (Yoga) or twice-weekly health and wellness classes which serve as a control for contact and participant burden (CTL). Assessments are conducted at baseline, 8 weeks, 3, 6, and 12 months of follow-up. The primary outcome is prolonged abstinence using an intention-to-treat approach. Multiple internal and external audits using blind data collection are employed to ensure treatment fidelity and reliability of study results. To understand why yoga may be more effective than CTL, we will examine the mechanisms of action (i.e., mediators) underlying intervention efficacy. We will examine the maintenance of yoga practice and smoking status at each follow-up. Focus groups and interviews will be used to enrich our understanding of the relationship of yoga practice and smoking abstinence. CONCLUSIONS: This study will provide a stringent test of the relative efficacy of yoga compared to a condition that controls for contact time and attention. The use of mixed methodology also provides the opportunity to validate existing knowledge about yoga and helps to explore new themes for future mindfulness and yoga research.

Medical Subject Headings (MeSH)
Age FactorsCognitive Behavioral TherapyFemaleHealth BehaviorHealth StatusHumansMaleMotivationReproducibility of ResultsResearch DesignSex FactorsSmoking CessationSubstance Withdrawal SyndromeTobacco Use DisorderYoga
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality85/10
Citation Metrics
Total Citations11
Citations/Year1.0
Relative Citation Ratio0.59
NIH Percentile32.1%
Research Impact Scores
APT Score0.50
Weight Score1.62
Normalized Score0.67
Related Supplements